142 related articles for article (PubMed ID: 19633917)
1. Pharmaceutical care for patients with ischemic stroke: improving the patients quality of life.
Hohmann C; Klotz JM; Radziwill R; Jacobs AH; Kissel T
Pharm World Sci; 2009 Oct; 31(5):550-558. PubMed ID: 19633917
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life after ischemic stroke: the impact of pharmaceutical interventions on drug therapy (pharmaceutical care concept).
Hohmann C; Radziwill R; Klotz JM; Jacobs AH
Health Qual Life Outcomes; 2010 Jun; 8():59. PubMed ID: 20565872
[TBL] [Abstract][Full Text] [Related]
3. Pharmaceutical care program for ischemic stroke patients: a randomized controlled trial.
Wang J; Wang J; Qiu S; Zhou C; Zhang H; Li Q; Sun S
Int J Clin Pharm; 2021 Oct; 43(5):1412-1419. PubMed ID: 33909194
[TBL] [Abstract][Full Text] [Related]
4. Pharmacist-led intervention study to improve drug therapy in asthma and COPD patients.
Ottenbros S; Teichert M; de Groot R; Griens F; Sodihardjo F; Wensing M; de Gier JJ
Int J Clin Pharm; 2014 Apr; 36(2):336-44. PubMed ID: 24293335
[TBL] [Abstract][Full Text] [Related]
5. Impact of community pharmaceutical care on patient health and quality of drug treatment in Parkinson's disease.
Schröder S; Martus P; Odin P; Schaefer M
Int J Clin Pharm; 2012 Oct; 34(5):746-56. PubMed ID: 22810890
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical care research and education project: patient outcomes.
Volume CI; Farris KB; Kassam R; Cox CE; Cave A
J Am Pharm Assoc (Wash); 2001; 41(3):411-20. PubMed ID: 11372906
[TBL] [Abstract][Full Text] [Related]
7. Patient-reported common symptoms as an assessment of interventions in medication reviews: a randomised, controlled trial.
Schoenmakers TWA; Wensing M; De Smet PAGM; Teichert M
Int J Clin Pharm; 2018 Feb; 40(1):126-134. PubMed ID: 29209863
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical care for migraine and headache patients: a community-based, randomized intervention.
Hoffmann W; Herzog B; Mühlig S; Kayser H; Fabian R; Thomsen M; Cramer M; Fiss T; Gresselmeyer D; Janhsen K
Ann Pharmacother; 2008 Dec; 42(12):1804-13. PubMed ID: 19001531
[TBL] [Abstract][Full Text] [Related]
9. Pharmacist consultations in general practice clinics: the Pharmacists in Practice Study (PIPS).
Tan EC; Stewart K; Elliott RA; George J
Res Social Adm Pharm; 2014; 10(4):623-32. PubMed ID: 24095088
[TBL] [Abstract][Full Text] [Related]
10. A non-randomized, controlled, interventional study to investigate the effects of community pharmacists' cognitive behavioral therapy-based interventions on medication adherence and relevant indicators in patients with depression.
Shoji M; Maeda H; Watanabe F; Tanuma K; Fujiwara A; Iwanaga Y; Shimada A; Onda M
BMC Psychiatry; 2023 Feb; 23(1):124. PubMed ID: 36829184
[TBL] [Abstract][Full Text] [Related]
11. Community Pharmacists Assisting in Total Cardiovascular Health (CPATCH): A Cluster-Randomized, Controlled Trial Testing a Focused Adherence Strategy Involving Community Pharmacies.
Blackburn DF; Evans CD; Eurich DT; Mansell KD; Jorgenson DJ; Taylor JG; Semchuk WM; Shevchuk YM; Remillard AJ; Tran DA; Champagne AP
Pharmacotherapy; 2016 Oct; 36(10):1055-1064. PubMed ID: 27581815
[TBL] [Abstract][Full Text] [Related]
12. Providing systematic detailed information on medication upon hospital discharge as an important step towards improved transitional care.
Hohmann C; Neumann-Haefelin T; Klotz JM; Freidank A; Radziwill R
J Clin Pharm Ther; 2014 Jun; 39(3):286-91. PubMed ID: 24877212
[TBL] [Abstract][Full Text] [Related]
13. Impact of pharmacist intervention on adherence and measurable patient outcomes among depressed patients: a randomised controlled study.
Aljumah K; Hassali MA
BMC Psychiatry; 2015 Sep; 15():219. PubMed ID: 26376830
[TBL] [Abstract][Full Text] [Related]
14. Effect of medication review and cognitive behaviour treatment by community pharmacists of patients discharged from the hospital on drug related problems and compliance: design of a randomized controlled trial.
Ahmad A; Hugtenburg J; Welschen LM; Dekker JM; Nijpels G
BMC Public Health; 2010 Mar; 10():133. PubMed ID: 20230611
[TBL] [Abstract][Full Text] [Related]
15. Effects of Chronic Care Model-based interventions on self-management, quality of life and patient satisfaction in patients with ischemic stroke: A single-blinded randomized controlled trial.
Kalav S; Bektas H; Ünal A
Jpn J Nurs Sci; 2022 Jan; 19(1):e12441. PubMed ID: 34264000
[TBL] [Abstract][Full Text] [Related]
16. A dual intervention in geriatric patients to prevent drug-related problems and improve discharge management.
Freyer J; Kasprick L; Sultzer R; Schiek S; Bertsche T
Int J Clin Pharm; 2018 Oct; 40(5):1189-1198. PubMed ID: 30051223
[TBL] [Abstract][Full Text] [Related]
17. Multifaceted intervention including motivational interviewing to support medication adherence after stroke/transient ischemic attack: a randomized trial.
Hedegaard U; Kjeldsen LJ; Pottegård A; Bak S; Hallas J
Cerebrovasc Dis Extra; 2014; 4(3):221-34. PubMed ID: 25598772
[TBL] [Abstract][Full Text] [Related]
18. [Utilising statutory health insurance data to evaluate pharmaceutical interventions in secondary care - a pilot study].
Wilke D; Schiek S; Bertsche T; Knoth H
Z Evid Fortbild Qual Gesundhwes; 2017 Apr; 121():21-28. PubMed ID: 28351625
[TBL] [Abstract][Full Text] [Related]
19. Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan.
Tasaka Y; Yasunaga D; Tanaka M; Tanaka A; Asakawa T; Horio I; Miyauchi Y; Araki H
Int J Clin Pharm; 2016 Apr; 38(2):321-9. PubMed ID: 26744362
[TBL] [Abstract][Full Text] [Related]
20. The impact of face-to-face educational outreach on diarrhoea treatment in pharmacies.
Ross-Degnan D; Soumerai SB; Goel PK; Bates J; Makhulo J; Dondi N; Sutoto ; Adi D; Ferraz-Tabor L; Hogan R
Health Policy Plan; 1996 Sep; 11(3):308-18. PubMed ID: 10160376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
